Wednesday, July 26, 2017 1:15:15 PM
DOVER, DE / ACCESSWIRE / February 1, 2017 / Metatron, Inc. (OTC PINK: MRNJ) announced today a reverse stock split of its common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of one-for-seventy- eight (1:78).
New SS from Feb 2, 2017:
Metatron Inc.
Authorized-2,500,000,000
Issued and outstanding-50,770,440
Restricted-8,846,557
"Metatron Inc. as of today, June 22, 2017"
Authorized: 2,500,000,000
Issued and Outstanding: 1,441,376,750
Restricted: 908,846,557
"Please see the share structure as of: 6-29-17"
Authorized: 6,000,000,000
Restricted: 908,846,557
Total Outstanding: 1,644,876,750
"The current share structure for Metatron Inc. as of today, July 11, 2017 is:"
Authorized: 6,000,000,000
Issued and Outstanding: 2,020,876,750
Restricted: 908,846,557
---
Traded Volume - Shares
July 12-25
2,308,487,848
---
DOVER, DE 6/23/2015
"Metatron Inc. a leader in mobile application development announced that it has completed a 1:10000 reverse split of its common stock Approved by FINRA it was announced June 23rd 2015 on their Daily List. This corporate action will take effect at the open of business 6/24/2015. The new symbol will be MRNJD. The “D” will be removed in 20 business days and the symbol will revert back to MRNJ. Fractional shares will be rounded up."
Recent MRNJ News
- Metatron Apps Unveils "Dr. AI" Health Assistant for Personalized Health Support • InvestorsHub NewsWire • 01/23/2024 01:23:40 PM
- Metatron Pioneers AI-driven Content Discovery and Issues Reverse Split Moratorium • InvestorsHub NewsWire • 12/12/2023 04:59:50 PM
- Alternative to AI-Powered Apps As ChatGPT Pauses Signups • AllPennyStocks.com • 11/20/2023 03:00:00 PM
- Alternative to AI-Powered Apps As ChatGPT Pauses Signups • AllPennyStocks.com • 11/20/2023 03:00:00 PM
- Firm Pioneers AI-Powered App with Real-Time Stock Insights • AllPennyStocks.com • 10/30/2023 06:30:00 PM
- Company Looks to Revolutionze Legal Communication with AI • AllPennyStocks.com • 09/25/2023 04:50:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM